Cargando…
miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
BACKGROUND: MicroRNAs (miRNAs) have been shown to be involved in the initiation and progression of cancers in the literature. In this study, we aimed to evaluate the clinicopathological role of miR-17 in breast cancer. MATERIALS AND METHODS: The expression of miR-17 was measured in 132 breast cancer...
Autores principales: | Yang, Fangliang, Li, Yuan, Xu, Lingyun, Zhu, Yulan, Gao, Haiyan, Zhen, Lin, Fang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293507/ https://www.ncbi.nlm.nih.gov/pubmed/28203087 http://dx.doi.org/10.2147/OTT.S127723 |
Ejemplares similares
-
Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012) -
A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer
por: Han, Ji-Guang, et al.
Publicado: (2017) -
Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015) -
miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
por: Gao, Bo, et al.
Publicado: (2023) -
miR-639 promotes the proliferation and invasion of breast cancer cell in vitro
por: Li, Lin, et al.
Publicado: (2014)